<ѻýҕl>FDA Slaps Restrictions on JAK Inhibitors Over Serious Safety Risksѻýҕl> Use for inflammatory conditions limited to those who fail on TNF blockers Sep 01, 2021
<ѻýҕl>What's Causing Cancer Patient's Joint Pain While on Checkpoint Inhibitor?ѻýҕl> Here is how clinicians diagnosed this rare inflammatory side effect Aug 30, 2021
<ѻýҕl>What Factors Predict RA in First-Degree Relatives?ѻýҕl> Study may offer insight into preclinical phase to identify factors that predict progression Aug 12, 2021
<ѻýҕl>JAK Inhibitor Tops Mab for Eczemaѻýҕl> New disease-modifying treatment option on the horizon Aug 04, 2021
<ѻýҕl>New-Onset IBD and IL-17 Inhibitors: What Is the Risk?ѻýҕl> Underlying inflammatory disease severity should be taken into account Jul 21, 2021
<ѻýҕl>FDA Approves IVIG for Dermatomyositisѻýҕl> Octagam 10% lands indication for adults following results of ProDERM trial Jul 20, 2021
<ѻýҕl>Slow Steroid Tapering Succeeds in SLEѻýҕl> Flare rates were significantly lower with gradual withdrawal than with low-dose maintenance Jul 13, 2021
<ѻýҕl>Skin Rash Should Be a Huge Red Flag for LVAD Recipients, Group Saysѻýҕl> New phenomenon suggests perils of not performing biopsy in time Jul 07, 2021
<ѻýҕl>Pain Persists in RA, Even Without Inflammationѻýҕl> At 5 years, one-third of patients with rheumatoid arthritis still had "unacceptable" pain Jun 22, 2021
<ѻýҕl>Osteoarthritis: A Link With Parkinson's?ѻýҕl> Inflammation may contribute to both joint and nerve degeneration Jun 09, 2021
<ѻýҕl>Secukinumab Shows Promise for Kids With Arthritisѻýҕl> More than 90% responded at week 12, study showed Jun 07, 2021
<ѻýҕl>Personalized Algorithm Helps Guide Rituximab Retreatmentѻýҕl> For ANCA-associated vasculitis, fixed retreatment not needed if naive B cells reappear Jun 05, 2021
<ѻýҕl>IVIG a Winner for Dermatomyositisѻýҕl> Pivotal phase III trial shows clear efficacy Jun 04, 2021
<ѻýҕl>Nintedanib Slows Decline in RA-Associated Interstitial Lung Diseaseѻýҕl> Similar results to original larger trial seen in post-hoc analysis Jun 04, 2021
<ѻýҕl>Oral JAK 1 Inhibitor Eases Spine Inflammation in Ankylosing Spondylitisѻýҕl> Treatment with filgotinib resulted in significant improvements compared with placebo Jun 04, 2021
<ѻýҕl>Even Exposure to Passive Smoking Increases Risk of RAѻýҕl> Disease onset was earlier in women exposed to smoky rooms during childhood Jun 03, 2021
<ѻýҕl>Rituximab a Hazard in RA Patients With COVIDѻýҕl> Poor outcomes were fourfold higher among rituximab users than for those on TNF inhibitors Jun 03, 2021
<ѻýҕl>'Talents' Land U.S. Researcher in Prisonѻýҕl> Ohio MD pleaded guilty to lying on grant applications, planned to share research with China May 19, 2021
<ѻýҕl>Op-Ed: Why the COVID Vaccine Didn't Work for Meѻýҕl> Millions of transplant patients need to be informed that they may not get sufficient protection May 10, 2021
<ѻýҕl>FDA Panel to Weigh Avacopan's Fate for ANCA Vasculitisѻýҕl> Agency staff called out "interpretability" of phase III trial results ahead of Thursday's meeting May 05, 2021
<ѻýҕl>'Dancing With the Stars' Judge Carrie Ann Inaba's Autoimmune Diseasesѻýҕl> TV host takes leave of absence May 04, 2021
<ѻýҕl>Delayed Diagnosis Common in Spinal Ailmentѻýҕl> Typical 7-year delay after symptom onset leaves patients at risk for irreversible damage Apr 30, 2021
<ѻýҕl>New Side Effect From mRNA COVID Vaccines?ѻýҕl> Surprise finding in Israeli case series Apr 15, 2021
<ѻýҕl>Perianal Involvement in Crohn’s Disease: How Bad for Prognosis?ѻýҕl> Poor outcomes noted, especially with severe phenotype Apr 14, 2021
<ѻýҕl>Pegloticase Safe for Dialysis Patients With Goutѻýҕl> Significant drop in monthly ESA dose seen after treatment, too Apr 09, 2021
<ѻýҕl>For Enthesitis in Psoriatic Arthritis, Target IL-23ѻýҕl> Targeted agent provides relief for many PsA patients Apr 08, 2021
<ѻýҕl>Refractory IBD: The Case for Doubling Up on Drugsѻýҕl> Meta-analysis suggests select patients can avoid surgery Apr 01, 2021
<ѻýҕl>JAK Inhibitor Promising in Psoriatic Arthritisѻýҕl> Oral agent noninferior to adalimumab in joint symptoms Apr 01, 2021
<ѻýҕl>Serious Infections Still Common in Vasculitisѻýҕl> Cyclophosphamide induction was riskier than rituximab Mar 23, 2021
<ѻýҕl>What to Tell Patients With Rheumatic/Musculoskeletal Diseases About COVID Vaccinesѻýҕl> New guidance from the American College of Rheumatology Mar 19, 2021
<ѻýҕl>Vasculitis Rates Rise With Earth's Latitudeѻýҕl> Highest rates for giant cell arteritis seen in Scandinavia, lowest in Hong Kong Mar 17, 2021
<ѻýҕl>Game Changer for Ulcerative Colitis Patients Failing Anti-TNF?ѻýҕl> JAK inhibitor helped when biologic didn't Mar 12, 2021
<ѻýҕl>Study Confirms Risk-Adapted CRS Prophylaxis for Acute Leukemiaѻýҕl> Tocilizumab reduced severe cytokine release syndrome in children, young adults Mar 09, 2021
<ѻýҕl>Combo Therapy Boosts Response in Uncontrolled Goutѻýҕl> "Markedly higher" rate than with pegloticase alone Mar 02, 2021
<ѻýҕl>Vedolizumab Tied to Lower Risk for Serious Infections in Ulcerative Colitisѻýҕl> But positive association versus TNF inhibitors not seen in Crohn's disease Mar 01, 2021
<ѻýҕl>Anakinra for Gout Flares: Is There a Role?ѻýҕl> IL-1 blockade was not superior to triamcinolone, but does have advantages Feb 23, 2021
<ѻýҕl>Lung Hemorrhage in Lupus: Which Patients Die?ѻýҕl> Risk factors include older age, longer disease duration, infection, and certain treatments Feb 20, 2021
<ѻýҕl>Avacopan for ANCA Vasculitis: A New Treatment Paradigm?ѻýҕl> Remission rates not inferior to prednisone -- the "unthinkable" achieved Feb 17, 2021
<ѻýҕl>Monoclonal Antibody Highly Effective in Phase III Psoriasis Trialѻýҕl> Beats ustekinumab, but main side effect was oral candidiasis Feb 05, 2021
<ѻýҕl>JAK Inhibitor Misses Endpoint in Safety Study. Now What?ѻýҕl> Major blow to popular class of oral rheumatology drugs Jan 27, 2021